VITAPHIL DHA beta carotene, ascorbic acid, cholecalciferol, alpha-tocopherol, thiamine hydrochloride, riboflavin, niacinamide, pyridoxine hydrochloride, folic acid, cyanocobalamin, biotin, calcium pantothenate, calcium carbonate, iron, magnesium oxide, zinc oxide, selenium, cupric oxide, choline bitartrate, doconexent kit |
Product Information | Product Type | HUMAN PRESCRIPTION DRUG LABEL | Item Code (Source) | NDC:68032-341 | |
Packaging | # | Item Code | Package Description | 1 | NDC:68032-341-60 | 1 KIT (KIT) in 1 CARTON | |
Quantity of Parts | Part # | Package Quantity | Total Product Quantity | Part 1 | 1 BOTTLE | 30 | Part 2 | 1 BOTTLE | 30 | |
Part 1 of 2 | VITAPHIL beta carotene, ascorbic acid, cholecalciferol, alpha-tocopherol, thiamine hydrochloride, riboflavin, niacinamide, pyridoxine hydrochloride, folic acid, cyanocobalamin, biotin, calcium pantothenate, calcium carbonate, iron, magnesium oxide, zinc oxide, selenium, cupric oxide, choline bitartrate tablet | |
Product Information | Item Code (Source) | NDC:68032-496 | Route of Administration | ORAL | DEA Schedule | | |
Active Ingredient/Active Moiety | Ingredient Name | Basis of Strength | Strength | BETA CAROTENE (BETA CAROTENE) | BETA CAROTENE | 2600 [iU] | ASCORBIC ACID (ASCORBIC ACID) | ASCORBIC ACID | 120 mg | CHOLECALCIFEROL (CHOLECALCIFEROL) | CHOLECALCIFEROL | 420 [iU] | ALPHA-TOCOPHEROL (ALPHA-TOCOPHEROL) | ALPHA-TOCOPHEROL | 20 [iU] | THIAMINE HYDROCHLORIDE (THIAMINE) | THIAMINE HYDROCHLORIDE | 3 mg | RIBOFLAVIN (RIBOFLAVIN) | RIBOFLAVIN | 3.5 mg | NIACINAMIDE (NIACINAMIDE) | NIACINAMIDE | 20 mg | PYRIDOXINE HYDROCHLORIDE (PYRIDOXINE) | PYRIDOXINE HYDROCHLORIDE | 30 mg | FOLIC ACID (FOLIC ACID) | FOLIC ACID | 1 mg | CYANOCOBALAMIN (CYANOCOBALAMIN) | CYANOCOBALAMIN | 12 ug | BIOTIN (BIOTIN) | BIOTIN | 30 ug | CALCIUM PANTOTHENATE (CALCIUM) | CALCIUM PANTOTHENATE | 8 mg | CALCIUM CARBONATE (CALCIUM) | CALCIUM CARBONATE | 100 mg | IRON (IRON) | IRON | 26 mg | MAGNESIUM OXIDE (MAGNESIUM OXIDE) | MAGNESIUM OXIDE | 50 mg | ZINC OXIDE (ZINC) | ZINC OXIDE | 15 mg | SELENIUM (SELENIUM) | SELENIUM | 50 ug | CUPRIC OXIDE (COPPER) | CUPRIC OXIDE | 2 mg | CHOLINE BITARTRATE (CHOLINE) | CHOLINE BITARTRATE | 60 mg | |
Inactive Ingredients | Ingredient Name | Strength | CELLULOSE, MICROCRYSTALLINE | | CROSCARMELLOSE SODIUM | | CROSPOVIDONE | | SILICON DIOXIDE | | MAGNESIUM STEARATE | | STEARIC ACID | | MALTODEXTRIN | | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | | SODIUM ALGINATE | | HYPROMELLOSE 2208 (100 MPA.S) | | POLYETHYLENE GLYCOL | | SUCROSE | | GELATIN | | STARCH, CORN | | ACACIA | | ALPHA-TOCOPHEROL, DL- | | SOYBEAN OIL | | TRIACETIN | | TITANIUM DIOXIDE | | FD&C BLUE NO. 1 | | FD&C YELLOW NO. 5 | | POLYSORBATE 80 | | |
Product Characteristics | Color | green | Score | no score | Shape | CAPSULE | Size | 20mm | Flavor | | Imprint Code | RE;341 | Contains | | |
Packaging | # | Item Code | Package Description | 1 | NDC:68032-496-30 | 30 TABLET (TABLET) in 1 BOTTLE | |
|
Marketing Information | Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date | unapproved drug other | | 11/14/2008 | 12/31/2011 | |
Part 2 of 2 | VITAPHIL DHA doconexent capsule, liquid filled | |
Product Information | Item Code (Source) | NDC:68032-497 | Route of Administration | ORAL | DEA Schedule | | |
Active Ingredient/Active Moiety | Ingredient Name | Basis of Strength | Strength | DOCONEXENT (DOCONEXENT) | DOCONEXENT | 200 mg | |
Inactive Ingredients | Ingredient Name | Strength | GELATIN | | WATER | | GLYCERIN | | POLYSORBATE 80 | | |
Product Characteristics | Color | yellow (Pale Yellow) | Score | no score | Shape | CAPSULE | Size | 20mm | Flavor | | Imprint Code | RE;499 | Contains | | |
Packaging | # | Item Code | Package Description | 1 | NDC:68032-497-30 | 30 CAPSULE, LIQUID FILLED (CAPSULE) in 1 BOTTLE | |
|
Marketing Information | Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date | unapproved drug other | | 11/14/2008 | 12/31/2011 | |
|
Marketing Information | Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date | unapproved drug other | | 11/14/2008 | 12/31/2011 | |